Molecular Partners and Roche Collaborate to Develop Protein-Drug Conjugates in Oncology
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 12 (Table of Contents)
Published: 20 Dec-2013
DOI: 10.3833/pdr.v2013.i12.1997 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Expanding the use of its DARPin® (designed ankyrin repeat proteins) biologics platform, Molecular Partners has entered into a research collaboration and licensing deal with Roche to discover, develop and commercialise multiple DARPin-drug conjugates in the field of oncology...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS